I. Dunkel

T. Merchant, C. Rodríguez-Galindo, M. Chintagumpala, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8.

J. Humm, R. Finn, K. Kramer, 2000, Medical and pediatric oncology.

Reirradiation for recurrent medulloblastoma

M. Souweidane, S. Wolden, O. Becher, 2011, Cancer.

High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.

W. Shi, J. Finlay, J. Garvin, 2010, Neuro-oncology.

New developments in the treatment of neutropenia.

J. Bussel, I. Dunkel, 1993, American journal of diseases of children.

CNS tumoursThe first study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed or refractory low-grade gliomas

B. Geoerger, J. Whitlock, D. Hargrave, 2016 .

Reduced-volume radiotherapy for patients with localized intracranial nongerminoma germ cell tumors

M. Souweidane, S. Wolden, O. Cahlon, 2017, Journal of Neuro-Oncology.

Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma.

M. Souweidane, S. Leibel, L. Happersett, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraocular Hemorrhage After Intra-Arterial Chemotherapy for Retinoblastoma in Sickle Cell Trait

S. Brodie, R. Folberg, Y. Gobin, 2012, The open ophthalmology journal.

Low‐grade glioma: A rare second tumor in retinoblastoma survivors

R. Kleinerman, D. Abramson, I. Dunkel, 2020, Pediatric blood & cancer.

Characteristics of oral mucosal events related to bevacizumab treatment.

M. Lacouture, V. Ramaswamy, M. Dickler, 2012, The oncologist.

Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma.

S. Brodie, C. Barker, S. Wolden, 2013, International journal of radiation oncology, biology, physics.

IMG-04. RESPONSE ASSESSMENT IN PEDIATRIC HIGH-GRADE GLIOMA: RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY WORKING GROUP

T. MacDonald, M. Prados, P. Wen, 2020, Neuro-Oncology.

Subarachnoid dissemination of intraventricular tumors following simultaneous endoscopic biopsy and third ventriculostomy.

M. Souweidane, P. Christos, J. Wellons, 2010, Journal of neurosurgery. Pediatrics.

Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era.

M. Rosenblum, T. Merchant, S. Leibel, 1996, International journal of radiation oncology, biology, physics.

Listeriosis in pediatric oncology patients

I. Dunkel, M. White, J. Mora, 1998, Cancer.

Septicemia and Septic Shock in Pediatric Patients: 140 Consecutive Cases on a Pediatric Hematology‐Oncology Service

G. Heller, G. Heller, A. Brown, 1998, Journal of pediatric hematology/oncology.

Retinoblastoma management in 13q deletion syndrome patients using super‐selective chemotherapies and other cancer‐directed interventions

S. Brodie, Y. Gobin, D. Abramson, 2020, Pediatric blood & cancer.

Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy

S. Brodie, Y. Gobin, D. Abramson, 2018, Neoplasia.

Carboplatin +/− Topotecan Ophthalmic Artery Chemosurgery for Intraocular Retinoblastoma

S. Brodie, Y. Gobin, D. Abramson, 2013, PloS one.

High‐dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma

M. Chintagumpala, R. Jubran, S. Goldman, 2010, Pediatric blood & cancer.

Published International Classification of Retinoblastoma (ICRB) Definitions Contain Inconsistencies—An Analysis of Impact

D. Abramson, I. Dunkel, Jonathan W. Kim, 2009, Ophthalmic genetics.

Impairments in antifolate transport are common in retinoblastoma tumor samples

R. Gorlick, D. Abramson, I. Dunkel, 2008, Pediatric blood & cancer.

A phase II trial of carboplatin for intraocular retinoblastoma

W. Shi, J. Finlay, D. Lyden, 2007, Pediatric blood & cancer.

CHAPTER 81 – Children's Oncology Group (COG) Trials for Retinoblastoma

J. Stoner, D. Friedman, M. Chintagumpala, 2007 .

Systemic carboplatin for retinoblastoma: change in tumour size over time

D. Abramson, I. Dunkel, K. Beaverson, 2005, British Journal of Ophthalmology.

New retinoblastoma tumor formation in children initially treated with systemic carboplatin.

D. Abramson, I. Dunkel, Thomas C. Lee, 2003, Ophthalmology.

Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastoma.

R. T. Gomez, D. Abramson, I. Dunkel, 1999, Ophthalmic genetics.

Brain stem tumors

M. Souweidane, I. Dunkel, 2005, Current treatment options in neurology.

Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the “head-start” I and II clinical trials

J. Finlay, Lingyun Ji, R. Sposto, 2018, Journal of Neuro-Oncology.

High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors

J. Finlay, M. Cairo, J. Garvin, 1998, Journal of Neuro-Oncology.

High-dose chemotherapy with autologous stem cell rescue for brain tumors.

J. Finlay, I. Dunkel, 2002, Critical reviews in oncology/hematology.

A Potential Role For Apparent Diffusion Coefficient in the Diagnosis of Trilateral Retinoblastoma

M. Souweidane, S. Karimi, D. Abramson, 2019, Journal of pediatric hematology/oncology.

Diffusion-weighted imaging to assess treatment response in a child with trilateral retinoblastoma

M. Rosenblum, A. Holodny, I. Dunkel, 2013, Pediatric Radiology.

Engraftment and growth of patient-derived retinoblastoma tumour in severe combined immunodeficiency mice.

S. Jhanwar, D. Abramson, I. Dunkel, 2000, European journal of cancer.

Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

J. Humm, S. Larson, M. Souweidane, 2022, Journal of Hematology & Oncology.

High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group.

J. Finlay, M. Cairo, J. Garvin, 1998, Journal of neuro-oncology.

Is there a role for high-dose chemotherapy with stem cell rescue for brain stem tumors of childhood?

J. Finlay, I. Dunkel, B. O'Malley, 1996, Pediatric neurosurgery.

Intra-arterial Chemotherapy for the Management of Retinoblastoma

S. Brodie, Y. Gobin, D. Abramson, 2017 .

Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: the Memorial Sloan-Kettering experience.

W. Gerald, E. Strong, D. Abramson, 1998, Medical and pediatric oncology.

Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma

S. Brodie, A. Daniels, Y. Gobin, 2014, PloS one.

The Location and Appearance of Second Malignancies in Patients With Bilateral Retinoblastoma

D. Abramson, I. Dunkel, S. Abramson, 1997, Sarcoma.

Neoplasms of the Eye

D. Abramson, I. Dunkel, A. Schefler, 2003 .

Sclerosing Epithelioid Fibrosarcomas Involving the Neuraxis: Report of Three Cases

M. Bilsky, M. Rosenblum, I. Dunkel, 2000, Neurosurgery.

Electroretinogram Monitoring of Dose-Dependent Toxicity after Ophthalmic Artery Chemosurgery in Retinoblastoma Eyes: Six Year Review

S. Brodie, E. Riedel, Y. Gobin, 2014, PloS one.

Ophthalmic artery chemosurgery for the management of retinoblastoma in eyes with extensive (>50%) retinal detachment

S. Brodie, Y. Gobin, S. Palioura, 2012, Pediatric blood & cancer.

Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity

D. Abramson, I. Dunkel, B. Marr, 2012, British Journal of Ophthalmology.

A Phase 2 Trial of Selumetinib in Children with Recurrent Optic Pathway and Hypothalamic Low-Grade Glioma without NF1: A Pediatric Brain Tumor Consortium Study.

A. Ligon, N. Lindeman, J. Fangusaro, 2021, Neuro-oncology.

Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.

Douglas C. Miller, M. Rosenblum, J. Finlay, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial

J. Fangusaro, E. Hwang, G. Robinson, 2020, Pediatric blood & cancer.

INTRAOPERATIVE ARACHNOID AND CEREBROSPINAL FLUID SAMPLING IN CHILDREN WITH POSTERIOR FOSSA BRAIN TUMORS

M. Souweidane, J. Rutka, P. Christos, 2009, Neurosurgery.

More aggressive bone marrow screening in retinoblastoma patients is not indicated: The memorial Sloan‐Kettering cancer center experience

S. Zacharoulis, D. Abramson, I. Dunkel, 2006, Pediatric blood & cancer.

Phase 1 study of dabrafenib in pediatric patients (pts) with relapsed or refractory BRAF V600E high- and low-grade gliomas (HGG, LGG), Langerhans cell histiocytosis (LCH), and other solid tumors (OST).

C. Pratilas, B. Geoerger, P. Haney, 2015 .

The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?

D. Abramson, I. Dunkel, A. Rizzuti, 2008, Archives of ophthalmology.

A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.

D. Abramson, I. Dunkel, C. M. Frank, 1999, Ophthalmology.

Orbital recurrence of retinoblastoma following enucleation

E. Riedel, D. Abramson, I. Dunkel, 2008, British Journal of Ophthalmology.

Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results

S. Brodie, Y. Gobin, D. Abramson, 2012, British Journal of Ophthalmology.

Genetic determinant of rapid-onset B-cell lymphoma by avian leukosis virus

W. S. Hayward, K. Beemon, R. Smith, 1997, Journal of virology.

Intra-arterial and Oral Digoxin Therapy for Retinoblastoma

S. Brodie, R. Folberg, C. Antczak, 2011, Ophthalmic genetics.

Spontaneously Resolving Periocular Erythema and Ciliary Madarosis Following Intra-arterial Chemotherapy for Retinoblastoma

S. Brodie, D. Abramson, I. Dunkel, 2010, Middle East African journal of ophthalmology.

Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma

S. Brodie, Y. Gobin, D. Abramson, 2009, Documenta Ophthalmologica.

Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy)

S. Brodie, A. Fabius, Y. Gobin, 2016, PloS one.

Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma

M. Ladanyi, M. Berger, D. Tsui, 2021, Ophthalmology science.

Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?

M. D. de Dávila, D. Abramson, I. Dunkel, 2004, British Journal of Ophthalmology.

Success of intra-arterial chemotherapy (chemosurgery) for retinoblastoma: effect of orbitovascular anatomy.

S. Brodie, Y. Gobin, D. Abramson, 2012, Archives of ophthalmology.

Trilateral retinoblastoma: Potentially curable with intensive chemotherapy

J. O'Brien, M. Souweidane, J. Finlay, 2010, Pediatric blood & cancer.

Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma

M. D. de Dávila, D. Abramson, I. Dunkel, 2007, Pediatric blood & cancer.

Delayed diagnosis of retinoblastoma: analysis of degree, cause, and potential consequences.

D. Abramson, I. Dunkel, L. Butros, 2002, Pediatrics.

Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.

S. Larson, M. Souweidane, Jason S. Lewis, 2018, The Lancet. Oncology.

Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.

Y. Gobin, D. Abramson, I. Dunkel, 2015, JAMA ophthalmology.

Histopathologic Findings of Eyes Enucleated After Treatment with Chemosurgery for Retinoblastoma

S. Brodie, R. Folberg, A. Moll, 2011, The open ophthalmology journal.

Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2‐chlorodeoxyadenosine

R. Arceci, J. Finlay, Jeffrey C. Allen, 2008, Pediatric blood & cancer.

Correlation of endoscopic biopsy with tumor marker status in primary intracranial germ cell tumors

M. Souweidane, I. Dunkel, M. Edgar, 2006, Journal of Neuro-Oncology.

Advances in the Management of Central Nervous System Germ Cell Tumors

I. Dunkel, N. Millard, 2014, Current Oncology Reports.

Psychiatric manifestations as initial presentation for pediatric CNS germ cell tumors, a case series

J. Garvin, A. Levy, I. Dunkel, 2016, Child's Nervous System.

Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes.

David T. W. Jones, T. MacDonald, M. Rosenblum, 2020, Cancer discovery.

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors

J. Huse, J. Kolesar, D. Lyden, 2017, PloS one.

Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.

D. Lyden, J. A. Heath, I. Dunkel, 2002, Journal of pediatric hematology/oncology.

A recurrent novel MGA–NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma

Andrew L. Kung, Minita Shah, Kazimierz O. Wrzeszczynski, 2018, Cold Spring Harbor molecular case studies.

Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma.

B. Geoerger, A. Pappo, C. Herzog, 2017, European journal of cancer.

Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study

B. Geoerger, J. Whitlock, D. Hargrave, 2019, Clinical Cancer Research.

A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation–Positive Solid Tumors

C. Pratilas, B. Geoerger, J. Whitlock, 2019, Clinical Cancer Research.

A phase IIa study of afuresertib, an oral pan‐AKT inhibitor, in patients with Langerhans cell histiocytosis

R. Arceci, M. Cornfeld, E. Jacobsen, 2017, Pediatric Blood & Cancer.

Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.

T. MacDonald, M. Prados, P. Wen, 2020, The Lancet. Oncology.

BRIM‐P: A phase I, open‐label, multicenter, dose‐escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation‐positive melanoma

A. Ferrari, YounJeong Choi, J. Chisholm, 2018, Pediatric blood & cancer.

Outcome of children less than three years old at diagnosis with non‐metastatic medulloblastoma treated with chemotherapy on the “Head Start” I and II protocols

J. Finlay, Lingyun Ji, R. Sposto, 2008, Pediatric blood & cancer.

Brainstem primitive neuroectodermal tumors (bstPNET): Results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue

Douglas C. Miller, M. Rosenblum, J. Finlay, 2008, Pediatric blood & cancer.

Recommendations for long-term follow-up of adults with heritable retinoblastoma.

M. Tucker, A. Moll, F. V. van Leeuwen, 2020, Ophthalmology.

Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study.

I. Pollack, C. Beattie, R. Packer, 2016, Neuro-oncology.

Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma

M. Karajannis, D. Abramson, I. Dunkel, 2022, Pediatric blood & cancer.

Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC

A. Fabius, Y. Gobin, D. Abramson, 2015, PloS one.

Psychosocial Outcomes in Adult Survivors of Retinoblastoma.

L. Robison, C. Sklar, K. Oeffinger, 2015, Journal of Clinical Oncology.

Whole‐body magnetic resonance imaging (WB‐MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: A pilot study

E. Lis, C. Sklar, K. Oeffinger, 2014, Pediatric blood & cancer.

Intra-Arterial Chemotherapy as a Treatment for Intraocular Retinoblastoma: Alternatives to Direct Ophthalmic Artery Catheterization

S. Brodie, M. Klufas, D. Abramson, 2012, American Journal of Neuroradiology.

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.

M. Rosenblum, J. Finlay, A. Yates, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

N. Schultz, M. Ladanyi, M. Berger, 2021, Nature Cancer.

ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium

K. Yeom, A. Panigrahy, S. Vajapeyam, 2022, American Journal of Neuroradiology.

A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study.

I. Pollack, A. Ligon, N. Lindeman, 2017 .

Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.

Douglas C. Miller, T. Zhou, S. Ingles, 2015, Pediatric neurology.

Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.

W. Mason, M. Rosenblum, T. Merchant, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAFV600E-Mutant Brain Tumor.

B. Taylor, K. Manova, M. Rosenblum, 2018, Cancer discovery.

The measurement of symptoms in children with cancer.

B. Rapkin, H. Thaler, T. Polyak, 2000, Journal of pain and symptom management.

Cell-free RB1 DNA not detected in the blood of pseudoretinoblastoma patients

M. Berger, A. R. Brannon, D. Mandelker, 2022, BMJ Open Ophthalmology.

Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: Outcome compared with conventional chemotherapy: A report from the Children's Oncology Group

M. Rosenblum, R. Zimmerman, I. Pollack, 2008, Pediatric blood & cancer.

Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): Report of the Head Start I and II experience

Douglas C. Miller, M. Rosenblum, J. Finlay, 2008, Pediatric blood & cancer.

D. Lyden, M. Karajannis, I. Dunkel, 2006, Journal of pediatric hematology/oncology.

Treatment approach for recurrent medulloblastoma

I. Dunkel, F. Malbari, 2015 .

A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis

Cheng Cheng, D. Pei, K. Nichols, 2018, Cancer.

Incidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction era.

Y. Gobin, D. Abramson, I. Dunkel, 2013, American journal of ophthalmology.

A phase I study of convection enhanced delivery (CED) of 124I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma (DIPG).

S. Larson, M. Souweidane, N. Cheung, 2017 .

Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutation

Andrew D. A. Maidment, B. Gallie, A. Maidment, 2011, International journal of cancer.

Benign outcome of RSV infection in children with cancer.

D. Armstrong, J. Stiles, I. Dunkel, 2001, Medical and pediatric oncology.

The Effect of Ophthalmic Artery Chemosurgery on Immune Function in Retinoblastoma Patients: A Single Institution Retrospective Analysis

M. Davis, I. Dunkel, C. Fischer, 2017, Journal of pediatric hematology/oncology.

Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience

J. Finlay, J. Fangusaro, G. Dhall, 2020, Pediatric blood & cancer.

BIOM-56. THE INTEGRATION OF A LIQUID BIOPSY PROGRAM INTO THE CARE OF PEDIATRIC BRAIN TUMOR PATIENTS

M. Souweidane, I. Mellinghoff, M. Arcila, 2020 .

Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system

M. Souweidane, S. Wolden, F. Boulad, 2010, Pediatric blood & cancer.

Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue

Douglas C. Miller, M. Rosenblum, J. Finlay, 2007, Pediatric blood & cancer.

Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.

S. Baruchel, M. Yalon, Jeffrey C. Allen, 2014, Neuro-oncology.

Melanoma in Children and Teenagers

C. Garbe, I. Dunkel, I. Brecht, 2020, Cutaneous Melanoma.

PDCT-13. PINEOBLASTOMA IN CHILDREN: THE HEAD START EXPERIENCE

J. Finlay, J. Fangusaro, G. Dhall, 2018, Neuro-Oncology.

Pontine glioma. Authors' reply

James L. Frazier, M. Souweidane, G. Jallo, 2009 .

Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma

S. Brodie, Y. Gobin, D. Abramson, 2012, PloS one.

Ophthalmic Artery Chemosurgery for Less Advanced Intraocular Retinoblastoma: Five Year Review

S. Brodie, Y. Gobin, S. Palioura, 2012, PloS one.

Lack of activity of oral etoposide for relapsed intraocular retinoblastoma

D. Abramson, I. Dunkel, G. Chantada, 2004, Ophthalmic genetics.

Adult Ophthalmic Oncology: Ocular Diseases

D. Abramson, I. Dunkel, A. Schefler, 2003 .

Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007–2017

C. Shields, A. Daniels, D. Abramson, 2018, British Journal of Ophthalmology.

Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results

S. Brodie, E. Zabor, Y. Gobin, 2011, British Journal of Ophthalmology.

Intraocular concentrations of chemotherapeutic agents after systemic or local administration.

T. Madden, W. Tong, D. Abramson, 1998, Archives of ophthalmology.

Primary Leptomeningeal Primitive Neuroectodermal Tumor

M. Rosenblum, E. Lis, D. Lyden, 2003, Journal of Neuro-Oncology.

ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma

S. Brodie, Y. Gobin, Y. Paulus, 2012, British Journal of Ophthalmology.

014 Intra-arterial chemotherapy (chemosurgery) in the ophthalmic artery for the treatment of retinoblastoma in children: 3 year experience

S. Brodie, D. Abramson, I. Dunkel, 2009, Journal of NeuroInterventional Surgery.

Intraventricular Meningioma After Cranial Irradiation for Childhood Leukemia

J. Huse, P. Steinherz, D. Ney, 2010, Journal of child neurology.

Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience

Julie L. Yang, A. Viale, M. Berger, 2020, Cancer medicine.

Brain Stem Glioma

M. Souweidane, I. Dunkel, 2010 .

Marker (+) CNS germ cell tumors in remission: Are surveillance MRI scans necessary?

M. Souweidane, S. Wolden, K. Kramer, 2014, Pediatric blood & cancer.

Recurrent ependymoma treated with high‐dose tamoxifen in a peripubertal female: Impact on tumor and the pituitary–ovarian axis

M. Souweidane, E. Lis, C. Sklar, 2007, Pediatric blood & cancer.

Hematopoietic Cell Transplantation for Brain Tumors

J. Finlay, I. Dunkel, 2007 .

Nondisseminated medulloblastoma in children less than three years of age: final report of the head start I and II protocols

Douglas C. Miller, M. Rosenblum, J. Finlay, 2007 .

A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors

J. Huse, J. Kolesar, D. Lyden, 2017, Pediatric blood & cancer.

Tandem thiotepa with autologous hematopoietic cell rescue in patients with recurrent, refractory, or poor prognosis solid tumor malignancies

J. Finlay, I. Dunkel, S. Gardner, 2018, Pediatric blood & cancer.

Ophthalmic artery chemosurgery for retinoblastoma prevents new intraocular tumors.

S. Brodie, Y. Gobin, D. Abramson, 2013, Ophthalmology.

INTRAVITREAL MELPHALAN AS SALVAGE THERAPY FOR REFRACTORY RETINAL AND SUBRETINAL RETINOBLASTOMA.

S. Brodie, D. Abramson, I. Dunkel, 2015, Retinal cases & brief reports.

Successful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intraarterial Chemotherapy (Ophthalmic Artery Chemosurgery).

Y. Gobin, D. Abramson, I. Dunkel, 2020, Ophthalmology. Retina.

Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.

Irwin I. Tendler, S. Brodie, Y. Gobin, 2015, Ophthalmology.

Intra-arterial chemotherapy for retinoblastoma.

S. Brodie, Y. Gobin, D. Abramson, 2012, Ophthalmology.

Chemotherapy‐induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention

G. Soff, S. Roberts, A. Mauguen, 2022, Pediatric blood & cancer.

Magnetic Resonance Imaging Screening for Trilateral Retinoblastoma: The Memorial Sloan Kettering Cancer Center Experience 2006-2016.

M. Souweidane, D. Abramson, I. Dunkel, 2019, Ophthalmology. Retina.

QOLP-24. PATIENTS’/PARENTS’ EXPERIENCES OF RECEIVING OPTUNE DELIVERED TUMOR TREATMENT FIELDS: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY: PBTC-048

G. Dhall, E. Hwang, S. Goldman, 2019, Neuro-Oncology.

PDCT-07. FEASIBILITY TRIAL OF TTFIELDS (TUMOR TREATING FIELDS) FOR CHILDREN WITH RECURRENT OR PROGRESSIVE SUPRATENTORIAL HIGH-GRADE GLIOMA (HGG) AND EPENDYMOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY: PBTC-048

J. Lai, G. Dhall, E. Hwang, 2018, Neuro-Oncology.

Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium

S. Vajapeyam, J. Fangusaro, M. Shiroishi, 2020, American Journal of Neuroradiology.

Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms

M. Ladanyi, M. Berger, A. Drilon, 2019, Nature Medicine.

Activating mutations in CSF-1R and additional receptor tyrosine kinases in histiocytic neoplasms

M. Ladanyi, M. Berger, A. Drilon, 2019, Nature Medicine.

Molecular Changes in Retinoblastoma beyond RB1: Findings from Next-Generation Sequencing

M. Berger, D. Mandelker, M. Donoghue, 2021, Cancers.

Intensity‐Modulated Radiation Therapy With Dose Painting: A Brain‐Sparing Technique for Intracranial Germ Cell Tumors

S. Terezakis, S. Wolden, I. Dunkel, 2016, Pediatric blood & cancer.

Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma

S. Brodie, A. Fabius, Y. Gobin, 2017, Ophthalmic genetics.

Alveolar soft part sarcoma of the bladder with ASPSCR1-TFE3 gene fusion as a secondary malignancy

C. Antonescu, N. Shukla, M. Walsh, 2017 .

The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors

J. Finlay, Lingyun Ji, R. Sposto, 2008, Pediatric blood & cancer.

A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study

C. Fuller, A. Waanders, M. DeWire, 2021, Clinical Cancer Research.

A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies

W. Gerald, H. Thaler, E. Lis, 2007, Pediatric blood & cancer.

Vancomycin‐resistant enterococcus in pediatric oncology patients: An analysis of potential consequences of colonization and infection

E. Riedel, L. Wexler, T. Small, 2009, Pediatric Blood & Cancer.

IMMU-08. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908

N. André, D. Hargrave, A. Gajjar, 2022, Neuro-Oncology.

Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study

M. Ladanyi, M. Berger, A. R. Brannon, 2023, PloS one.

Longitudinal MR spectroscopic imaging of pediatric diffuse pontine tumors to assess tumor aggression and progression.

S. Karimi, J. Koutcher, S. Thakur, 2006, AJNR. American journal of neuroradiology.

Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908

N. André, D. Hargrave, A. Gajjar, 2023, Neuro-oncology.

Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery

S. Brodie, A. Mauguen, Y. Gobin, 2018, PloS one.

Experience of intra-arterial chemosurgery with single agent carboplatin for retinoblastoma

S. Brodie, Y. Gobin, D. Abramson, 2012, British Journal of Ophthalmology.

Risk Factors for Severe Neutropenia following Intra-Arterial Chemotherapy for Intra-Ocular Retinoblastoma

S. Brodie, W. Shi, Y. Gobin, 2014, PloS one.

High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma

J. Finlay, I. Dunkel, 1996, Journal of Neuro-Oncology.

Slipped capital femoral epiphyses: A major on‐target adverse event associated with FGFR tyrosine kinase inhibitors in pediatric patients

M. Karajannis, I. Dunkel, Z. Antal, 2023, Pediatric blood & cancer.

Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates.

R. Portenoy, J. Collins, I. Dunkel, 1999, The Journal of pediatrics.

Novel use of zolpidem in cerebellar mutism syndrome.

M. Souweidane, I. Dunkel, T. Gershon, 2011, Journal of pediatric hematology/oncology.

General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study

L. Robison, C. Sklar, K. Oeffinger, 2021, Pediatric blood & cancer.

Vision-Targeted Health-Related Quality of Life in Adult Survivors of Retinoblastoma

L. Robison, C. Sklar, K. Oeffinger, 2018, JAMA ophthalmology.

Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: an initial report

Y. Gobin, D. Abramson, I. Dunkel, 2022, Ophthalmic Genetics.

Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed refractory low-grade glioma.

N. André, B. Geoerger, J. Whitlock, 2018 .

Twenty-Year Collaboration Between North American and South American Retinoblastoma Programs

D. Abramson, I. Dunkel, G. Chantada, 2016, Journal of global oncology.

Intensive multi-modality therapy for extra-ocular retinoblastoma (RB): A Children's Oncology Group (COG) trial (ARET0321).

T. Merchant, C. Rodríguez-Galindo, M. Chintagumpala, 2017 .

LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B

David T. W. Jones, A. Panigrahy, S. Pfister, 2019, Neuro-Oncology.

Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial

S. Larson, M. Souweidane, Jason S. Lewis, 2018 .

IMMU-09. OUTCOME OF PATIENTS WITH RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) TREATED WITH PEMBROLIZUMAB (ANTI-PD-1): A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC045)

A. Onar, E. Hwang, M. Fouladi, 2018, Neuro-Oncology.

DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

Noah E. Berlow, Elaine C. Huang, T. Lagerweij, 2012 .

Dabrafenib, alone or in combination with trametinib, in BRAF V600–mutated pediatric Langerhans cell histiocytosis

B. Geoerger, D. Hargrave, M. Roughton, 2023, Blood advances.

LGG-04. A PHASE II RE-TREATMENT STUDY OF SELUMETINIB FOR RECURRENT OR PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (pLGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

I. Pollack, J. Fangusaro, R. Packer, 2020, Neuro-Oncology.

A phase I study of convection-enhanced delivery of 124I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma: An update with dose-response assessment.

S. Larson, M. Souweidane, N. Cheung, 2019, Journal of Clinical Oncology.

Trilateral retinoblastoma: potentially curable with intensive chemotherapy.

J. O'Brien, M. Souweidane, J. Finlay, 2010, Pediatric blood & cancer.

DIPG-22. A PHASE 1 TRIAL OF THE HISTONE DEACETYLASE INHIBITOR PANOBINOSTAT IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

M. Monje, J. Fangusaro, K. Warren, 2018, Neuro-Oncology.

Next-generation Sequencing of Cerebrospinal Fluid for Clinical Molecular Diagnostics in Pediatric, Adolescent and Young Adult (AYA) Brain Tumor Patients.

M. Berger, M. Souweidane, I. Mellinghoff, 2022, Neuro-Oncology.

Subconjunctival corticosteroids for benign lymphoid hyperplasia

T. Chikama, N. Morishige, I. Dunkel, 2005, British Journal of Ophthalmology.

Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults

E. Calleja, N. Cheung, K. Kramer, 2001, Bone Marrow Transplantation.

Whole‐body magnetic resonance imaging (WB‐MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: A pilot study

E. Lis, C. Sklar, K. Oeffinger, 2014, Pediatric blood & cancer.

Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).

S. Brodie, Y. Gobin, I. Dunkel, 2010, Ophthalmology.

A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1).

C. Rodríguez-Galindo, M. Chintagumpala, R. Jubran, 2023, Pediatric blood & cancer.

Rapid induction of B-cell lymphomas by avian leukosis virus.

W. S. Hayward, K. Beemon, R. Smith, 1997, Leukemia.

LGG-55. OUTCOME OF BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION

I. Harting, L. Hazrati, D. Eisenstat, 2020, Neuro-Oncology.

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes. Discovery.

Moore, M. Snuderl, M. Preusser, 2020 .

A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC‐042)

S. Leary, J. Phillips, G. Dhall, 2020, Pediatric blood & cancer.

Letter to the Editor regarding clinical debate concerning treatment of pediatric LGG by Cooney et al.

M. Souweidane, M. Karajannis, I. Dunkel, 2020, Neuro-oncology practice.

A Phase I Trial of Panobinostat in Children with Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium (PBTC-047).

J. Fangusaro, D. Faury, N. Jabado, 2023, Neuro-oncology.

LTBK-01. UPDATES ON THE PHASE II AND RE-TREATMENT STUDY OF AZD6244 (SELUMETINIB) FOR CHILDREN WITH RECURRENT OR REFRACTORY PEDIATRIC LOW GRADE GLIOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

I. Pollack, A. Ligon, N. Lindeman, 2018, Neuro-Oncology.